Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Elixir Department: SOP for Vendor Qualification for Raw Materials – V 2.0

Posted on By

Elixir Department: SOP for Vendor Qualification for Raw Materials – V 2.0

Standard Operating Procedure for Vendor Qualification for Raw Materials in Elixir Manufacturing

Department Elixir Department
SOP No. SOP/ELX/249/2025
Supersedes SOP/ELX/249/2022
Page No. Page 1 of 9
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To establish a formal procedure for evaluating, qualifying, monitoring, and approving vendors supplying raw materials (APIs, excipients, solvents, etc.) used in elixir manufacturing to ensure consistent material quality and regulatory compliance.

2. Scope

This SOP applies to the qualification of all vendors supplying raw materials for use in the Elixir Department, including initial qualification, requalification, and disqualification processes.

3. Responsibilities

  • Purchase Department:
    • Initiate vendor selection and send qualification questionnaire.
  • Quality Assurance (QA):
    • Coordinate vendor audits, maintain vendor files, and approve qualification status.
  • Quality Control (QC):
    • Evaluate material quality and provide analytical feedback.

See also  Elixir Department: SOP for Alcohol Strength Adjustment in Final Product - V 2.0

4. Accountability

The Head of QA is accountable for ensuring that vendors are qualified and monitored in accordance with this SOP and regulatory standards.

5. Procedure

5.1 Vendor Selection

  1. Purchase department identifies potential vendor based on:
    • GMP compliance
    • Geographical reliability
    • Business
reputation
  • Send Vendor Qualification Questionnaire (Annexure-1).
  • 5.2 Vendor Evaluation

    1. QA reviews questionnaire for:
      • Manufacturing site licenses
      • Quality systems in place
      • CoAs and test methods used
      • Regulatory approvals (e.g., WHO, FDA, etc.)
    2. Evaluate at least 3 commercial lots of material before provisional approval.

    5.3 Vendor Audit

    1. QA shall schedule and conduct on-site audits for high-risk or critical vendors (APIs, solvents).
    2. Audit checklist (Annexure-2) must cover:
      • Facility and equipment hygiene
      • Documentation and data integrity
      • Process controls
    3. Audit report with CAPA (if any) to be submitted within 10 working days of audit.

    5.4 Approval and Listing

    1. QA reviews audit and analytical evaluation outcomes.
    2. If satisfactory, add vendor to Approved Vendor List (Annexure-3).
    3. Assign vendor status: Approved, Conditionally Approved, or Rejected.

    5.5 Requalification and Monitoring

    1. Conduct requalification every 2 years or after any major quality issue.
    2. Monitor vendor performance using:
      • Rejection trends
      • OOS/OOT results
      • Customer complaints (if applicable)

    5.6 Disqualification

    1. QA may disqualify a vendor based on:
      • Repeated quality failures
      • Unresolved audit observations
      • Breach of GMP compliance
    2. Document disqualification reason and notify the purchase department.

    6. Abbreviations

    • SOP: Standard Operating Procedure
    • QA: Quality Assurance
    • QC: Quality Control
    • CoA: Certificate of Analysis
    • OOS: Out of Specification
    • CAPA: Corrective and Preventive Action

    7. Documents

    1. Vendor Qualification Questionnaire (Annexure-1)
    2. Vendor Audit Checklist (Annexure-2)
    3. Approved Vendor List (Annexure-3)

    8. References

    • ICH Q7 – Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
    • WHO TRS 1010 – GMP for Pharmaceutical Products
    • 21 CFR Part 211 – cGMP for Finished Pharmaceuticals

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Vendor Qualification Questionnaire

    Vendor Name Site Address License No. GMP Compliance Primary Contact
    Shakti Excipients Ltd. Navi Mumbai, Maharashtra MH/FDA/2023/236 WHO-GMP Mr. Rajesh Kumar

    Annexure-2: Vendor Audit Checklist

    Audit Area Compliant (Yes/No) Observations
    Facility Hygiene Yes Meets expectations
    Documentation Control No SOPs not version-controlled

    Annexure-3: Approved Vendor List

    Vendor Name Material Supplied Approval Date Status
    Shakti Excipients Ltd. Sorbitol Solution 01/04/2025 Approved

    Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By
    01/01/2024 1.0 Initial Release New SOP QA Head
    11/04/2025 2.0 Added disqualification process and updated annexures Process Enhancement QA Head
    See also  Elixir Department: SOP for Cleaning During Campaign Manufacturing - V 2.0
    Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

    Post navigation

    Previous Post: Analytical Method Development: SOP for Handling and Qualification of Analytical Reference Standards – V 2.0
    Next Post: Analytical Method Development: SOP for Calibration of UV-Visible Spectrophotometer – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version